阳离子基因载体的pH敏感遮蔽体系的制备及表征

合成了一种pH敏感的遮蔽体系-谷氨酸苄酯/谷氨酸共聚物(PBLG-co-PGA), 用于对DNA/阳离子基因载体复合物颗粒表面正电荷的遮蔽, 以提高其在体内的稳定性. 研究表明, PBLG-co-PGA (PGA(x), x为PGA占共聚物中摩尔百分数)具有pH敏感性. 并以pH敏感点接近生理pH值的PGA(60)为遮蔽体系进行研究. PGA(60)能够对DNA/PEI(1:1)复合物颗粒表面正电荷进行有效遮蔽. 凝胶阻滞电泳显示, 用PGA(60)对DNA/PEI复合物进行不同比例遮蔽, 没有发生与DNA的链交换作用. MTT细胞毒性测试表明, PGA(60)和三元复合物DNA/PEI/PGA(60) 在测试范围内几乎没有细胞毒性. 荧光素酶转染实验表明, 部分遮蔽后转染效率有所提高; 用PGA(60)对DNA/PEI复合物完全遮蔽为负电后, 由于同细胞表面的电荷排斥作用, 三元复合物不易被细胞内吞, 导致不发生细胞转染. 因其合适的pH响应性, PGA(60)将可能成为一种能随pH值的变化, 实现对聚阳离子基因载体进行电荷遮蔽/智能释放的遮蔽材料.     

PEI基因载体靶向遮蔽体系的制备和表征

将RGD短肽接枝到聚谷氨酸(PGA)上,制备了一种靶向性的基因载体遮蔽材料PGA-RGD.通过凝胶电泳实验及体外转染实验证明得出RGD的引入增加了载体材料与细胞表面受体的特异性作用,在载体表面正电荷得到遮蔽的同时,转染效率还得到了一定程度的增加.同时,对转染了48h的三元复合物进行MTT细胞毒性测试表明,PGA遮蔽的基因载体体系(PGA/PEI/DNA)和PGA-RGD遮蔽的基因载体体系(PGA-RGD/PEI/DNA)的细胞毒性均低于PEI/DNA复合物体系.本文开发的基因载体改性方法不仅可以对复合物颗粒表面的正电荷进行遮蔽,从而降低复合物体系对非目标组织的非特性异作用;同时引入的RGD靶向短肽还可以提高载体的靶向性,这一改性策略对推动阳离子聚合物基因载体在体内的应用具有重要意义.     

PEI-g-MPEG/白细胞介素-10基因传递系统转染背根神经节细胞的体外性能研究

探索非病毒基因载体聚乙二醇-聚乙烯亚胺共聚物(PEI-g-MPEG)介导白细胞介素-10(Interleukin-10,IL-10)体外转染原代培养背根神经节细胞(dorsal root ganglion cells,DRGs)的效果.采用本实验室设计合成的PEI-g-MPEG,与同时携带增强型绿色荧光蛋白报告基因及IL-10基因的真核表达质粒DNA(pDC316-EGFP/IL-10)形成复合物,以脂质体(lipofectamine)复合体系Lipo/pDNA为对照,通过溴乙啶(ethidiumbromide,EB)排斥实验、凝胶阻滞电泳实验、粒径与电位的测定及扫描电镜等实验方法观察PEI-g-MPEG/pDNA的复合效果.并且检测了复合物对DRGs的毒性、转染效果及IL-10的蛋白表达情况.结果表明,PEI-g-MPEG在N/P(PEI-g-MPEG所含的氮原子和质粒DNA中磷原子的摩尔比)为5时可完全复合pDNA;随着N/P的增大,PEI-g-MPEG/pDNA复合物的粒径逐渐减小,而表面电位逐渐增大;在N/P为15时报告基因转染效果和IL-10蛋白表达情况较好,复合物的形貌呈大小均一的球形.PEI-g-MPEG/IL-10基因传递系统对于神经病理性疼痛的基因治疗具有潜在应用价值.     

ATRP法制备聚(甲基丙烯酸氨乙酯-co-甲基丙烯酸N,N-二乙基氨乙基酯)基因载体

为得到低毒、高效的聚阳离子基因载体,以甲基丙烯酸氨乙酯(AMA)和甲基丙烯酸N,N-二乙基氨乙基酯(DEAEMA)为单体,以2-溴代异丁酸乙酯(EBIB)为引发剂,通过原子转移自由基聚合(ATRP)制备了两种聚(甲基丙烯酸氨乙酯-co-甲基丙烯酸N,N-二乙基氨乙基酯)阳离子无规共聚物(P(AMA-co-DEAEMA),简称P).琼脂糖凝胶电泳实验结果表明聚合物P作为阳离子载体可以有效地络合DNA,通过粒径仪测定的复合物粒子的尺寸在400 ～ 600 nm之间.扫描电镜观察的P/DNA复合物形貌是分散均匀的球形颗粒.以25kDa PEI为阳性参照,利用MTT比色法考察了聚合物P对HEK293T细胞的毒性.结果表明,聚合物P的细胞毒性低于25 kDa PEI的细胞毒性.以25 kDa PEI和裸质粒DNA作为参照,我们进一步考察了聚合物P与DNA形成的复合物在HEK293T细胞中的转染效率.结果表明P/DNA复合物在HEK293T细胞中的转染效率远远高于裸质粒DNA的转染效率,并且接近于25 kDa PEI/DNA复合物的转染效率.     

普鲁兰多糖为骨架的新型阳离子非病毒基因载体

通过琥珀酸酐将低分子量支化聚乙烯亚胺(PEI, 分子量1000)偶联到普鲁兰多糖(Pullulan)上, 合成了新型基因载体P-PEI. 利用 ¹H NMR、 FTIR、 粒度仪、 Zeta电位仪、 透射电镜和凝胶电泳对聚阳离子载体及其与质粒pDNA 的复合物进行了表征. 凝胶阻滞实验结果证明, 载体P-PEI在体外可以通过静电相互作用稳定结合pDNA, 并能有效抑制DNA水解酶及血清成分对pDNA的降解. 噻唑蓝(MTT)细胞毒性测试、 绿色荧光蛋白表达质粒(pGFP)及荧光素酶表达质粒(pGL3)转染实验结果表明, 载体P-PEI在N/P高达12.5时对细胞MCF-7, HeLa和COS-7的毒性低于PEI; 当N/P 为6.25时能有效将pGFP和pGL3带入Hela 细胞并表达, 最佳转染效率及荧光素酶活分别为, 比Lipo 2000[(49.13±0.61)%, (58.47±7.62)×10⁸ RLU/mg蛋白) 略低. 因此以Pullulan为骨架材料的P-PEI是一种新的有潜在应用价值的非病毒基因载体.     

聚苯丙氨酸修饰低分子量聚乙烯亚胺制备高效基因载体

分别制备了以支化小分子量聚乙烯亚胺(PEI-1.8k)为引发剂,引发苯丙氨酸-NCA开环聚合得到聚乙烯亚胺-聚苯丙氨酸(PEI1.8k-g-PPhe)以及聚乙烯亚胺接枝苯丙氨酸单体(PEI1.8k-g-Phe)的系列基因载体材料.利用核磁、粒度、zeta电位仪、荧光光度计、流式细胞仪以及激光共聚焦显微镜对PEI1.8k-g-PPhe,PEI1.8k-g-Phe以及PEI1.8k-g-PPhe/DNA和PEI1.8k-g-Phe/DNA复合物颗粒进行了系统的表征.研究结果表明,最佳转染条件下,PEI1.8k-g-PPhe10/DNA复合物颗粒的粒径约为150 nm,表面电位约为16 m V.在人源宫颈癌(He La)和人源乳腺癌(MCF-7)2种细胞系中均具有较高的基因转染效率,且最佳转染效率可达到PEI-25k的12倍.MTT细胞毒性实验分别比较了PEI1.8k-g-PPhe和PEI1.8k-g-Phe对He La细胞毒性的大小.从实验结果可见,苯丙氨酸引入的方式及数量决定着其细胞毒性的大小.PEI1.8k-g-PPhe和PEI1.8k-g-Phe都具有较低的细胞毒性(材料在较高浓度1 mg/m L时的细胞存活率大于70%).内吞实验结果表明,PEI1.8k-g-PPhe由于接入了具有规则聚合链的聚苯丙氨酸,而易于被He La细胞内吞.PEI1.8k-g-PPhe10/DNA复合物颗粒相比于PEI-25k/DNA,PEI-1.8k/DNA和PEI1.8k-g-PPhe/DNA具有更高的细胞内吞效率.     

聚谷氨酸为骨架的梳状基因载体的合成及生物学性能评价

以聚谷氨酸为骨架, 用低分子量聚乙烯亚胺胺解聚谷氨酸苄酯, 得到聚谷氨酸-g-聚乙烯亚胺, 用异佛尔酮二异氰酸酯将聚乙二醇单甲醚偶联到聚谷氨酸-g-聚乙烯亚胺上, 合成了梳状聚阳离子基因载体聚谷氨酸-g-(聚乙烯亚胺-b-聚乙二醇). 利用核磁共振氢谱、 激光粒度分析仪、 Zeta电位仪和凝胶电泳对聚阳离子载体及其与质粒脱氧核糖核酸(pDNA)形成的复合物进行了表征. 通过噻唑蓝(MTT)细胞毒性测试、 绿色荧光蛋白质粒pEGFP-C1及荧光素酶质粒pGL3体外转染实验考察了载体的细胞毒性及基因转染效率. 结果表明, 当聚乙烯亚胺中N原子和DNA中P原子的摩尔比(N/P)大于5时, 载体能很好地包裹DNA, 载体与DNA形成的复合物粒径约为130 nm, Zeta电位约为28 mV; 通过MTT实验和体外质粒转染实验显示出载体在测量范围内具有极低的细胞毒性和较高的转染效率.     

反向基因转染技术的最近研究进展

随着基因治疗研究的深入,基因转染技术得到了长足的发展。在反向基因转染概念被提出来的十余年间,反向基因转染技术也引起了广泛关注。反向基因转染技术是相对于常规转染而言的,即首先通过基质锚定DNA(或RNA),然后将细胞接种于该基质表面,细胞贴附的同时摄取锚定的DNA(或RNA)而实现基因转染,因而也被称为表面介导基因转染、基质介导基因转染、固相基因转染。与传统转染方法相比,其具备以下优势:载体/DNA(或RNA)复合物更加稳定,转染试剂可以更有效地接触细胞而达到更高的转染效率,低的细胞毒性和血清环境中不影响转染效率等。本文主要综述了反向转染技术的最新研究进展及其主要应用领域。     

六方向核聚酰胺-胺树形高分子的合成及其介导的基因转移

设计、合成、表征以肌醇为六方向起始核的新型聚酰胺-胺树形高分子. 第三代至第六代树形高分子(G3~G6)能够和DNA通过电荷相互作用形成聚电解质复合物, 聚酰胺-胺树形高分子G6和荧光素酶基因(pRE Luc)形成的复合物的粒径为80~300 nm. G3~G6能介导半乳糖苷酶基因(pSV β-Gal)和荧光素酶基因有效转染HeLa和HEK293细胞. G5和G6的转染效率比聚赖氨酸高得多, 接近枝化聚乙烯亚胺(branched polyethylenimine, PEI, Mw 25 K)的转染效率. G5和G6的细胞毒性低于聚-L-赖氨酸.     

交联型聚乙烯亚胺智能基因载体的制备及PEG化影响

使用胱胺双丙烯酰胺(CBA)对低分子量聚乙烯亚胺(PEI)进行交联反应制备智能降解型聚阳离子基因载体.通过与聚乙二醇(PEG)反应得到不同程度PEG化的聚阳离子载体.利用核磁、黏度测试、粒度仪、zeta电位仪和凝胶电泳对聚阳离子载体及其与DNA的复合物进行了表征.研究表明随着PEG含量的增加,聚阳离子载体/DNA复合物颗粒粒径变小、表面正电荷降低,PEG具有明显的屏蔽作用,但过多的PEG也使载体与DNA复合能力下降.通过MTT细胞毒性测试和荧光素酶质粒转染实验得出,含二硫键的交联型阳离子聚合物在测试范围内显示了非常低的细胞毒性,最佳转染效率是PEI25k的4倍,PEG化后其细胞毒性得到进一步改善,转染效率却明显降低.     

负载肝素及生物素化肝素修饰的纳米粒子的基质介导基因传递系统

首先通过静电作用将带负电荷的肝素及生物素化肝素和带正电荷的PAMAM/DNA自组装,分别制备了PAM AM/DNA/heparin和PAMA M/DNA/heparin-biotin复合物,然后用快速降解胆酸功能化星型聚(DL-丙交酯)作为基质、并加入水溶性高分子α,β-聚(N-2-羟乙基)-L-天冬酰胺(PHEA)作...     

超顺磁性DNA纳米富集器应用于痕量寡聚核苷酸的富集

随着纳米技术的迅速发展 ,纳米材料逐渐被应用到细胞生物学和分子生物学研究领域 ,为生物医学的研究和发展提供了新的技术和手段 [1～ 4 ] .如超顺磁性纳米颗粒由于具有尺寸小、比表面积大、悬浮稳定性好及在外磁场作用下的磁导向性运输和富集等优良特性 ,使其在细胞和生物活性     

Hydrogen bonds in polycation improve the gene delivery efficiency in the serum-containing environment

Cationic polymers with high charge density could effectively condense the DNA and achieve gene transfection; however, it often brings non-negligible cytotoxicity. Notably, the high charge density gene vector fails in the serum environment, limiting further application in vivo. In this paper, an efficient and reliable non-viral gene vector of poly (amidoamine) (PAA) was designed by introducing diacryolyl-2,6-diaminopyridine (DADAP) onto the PAA backbone through Michael-addition polymerization, which provides high transfection efficiency in a serum-containing environment. Diacryolyl-2,6-diaminopyridine and cationic parts provided multiple interactions between gene vectors and DNA, including hydrogen bond and electrostatic interactions. The introduction of hydrogen bonding can effectively reduce the charge density of polyplexes without reducing the DNA condensing ability, incorporating the diaminopyridine group and cationic part in PAA chains successfully consolidated cellular uptake, endosome destabilization, and transfection efficiency for the PAA/DNA complexes with low cytotoxicity. The constructed vector with multiple interactions presented 6 times higher transfection efficiency in serum-free and 9 times in serum-containing environment than that of branched polyethyleneimine (PEI 25K) in 293T cells in vitro. Therefore, introducing the hydrogen band to form low charge density polyplexes with high transfection efficiency and low cytotoxicity has a great potential in gene delivery.     

Bioreducible crosslinked low molecular weight branched PEI-PBLG as an efficient gene carrier

Low molecular weight polyethylenimine-poly(gamma-benzyl L-glutamate) (PEI-PBLG) was crosslinked by N,N′-cystamine-bisacrylamide (CBA) to get the polymer named as CBA-PEI-PBLG (CPP). CPP not only inherits PEI-PBLG’s amphiphilic advantages, but also possesses reducible properties. CPP can complex with DNA to form nanoparticles. CPP/DNA complex particles were characterized by particle size and zeta potential analysis. The result showed that the complex particles have suitable size and surface charges for gene delivery. And gel retardation assay also prove CBA-PEI-PBLG has proper condensing ability for DNA. CPP has good reducible property, and also has good biocompatibility because of introducing PBLG segment. The cytotoxicity of CPP was evaluated using MTT assay, and the results showed CPP has lower cytotoxicity compared with PEI 25 K. The transfection properties were characterized in different cells by using plasmid DNA as a reporter. CPP showed higher transfection efficiencies and lower cytotoxicity in HeLa cells. This was attributed to bioreducible and biocompatibility properties of the CPP. These results suggested that CPP is a promising low-toxic, highly effective non-viral gene carrier.     

Hydrolyzable p(DMAPEMA) polymers for gene delivery

The efficiency of cationic polymers as transfectants is thought to be closely related to their DNA association/dissociation properties. An incomplete polymer-DNA dissociation could explain the relatively low gene expression obtained with p(DMAEMA) polymers. Our approach was to synthesize a p(DMAEMA) analogue, p(DMAPEMA), bearing an hydrolyzable cationic group incorporated into the pendant chain with a view to improving transfection. The complexation of DNA with both polymers was studied by agarose gel electrophoresis, size and zeta potential measurements, as well as the dissociation of the polyplexes, after treatment by an anionic polymer, sodium hydroxide or heat. The transfection efficiencies of the polyplexes were evaluated with 293T and BHK21 cells in comparison with Exgen 500. P(DMAPEMA) polymers were able to complex DNA and to release it in a free intact form after an alkaline treatment or storage at 37 degrees C. Poly(aspartic acid) was unable to dissociate p(DMAPEMA) based polyplexes, in contrast to p(DMAEMA) ones. No transfection was obtained with p(DMAPEMA) with both cell lines. A slow hydrolysis under physiological conditions resulting in the absence of DNA unpacking or endosomal entrapment could explain these results. Better transfection results were obtained with polyplexes which were able to be dissociated by electrostatic interactions rather than ones which required the hydrolysis mechanism to release free DNA into cells. Scheme of hydrolyzable p(DMAPEMA) polymer.     

Hyaluronic acid and chitosan-DNA complex multilayered thin film as surface-mediated nonviral gene delivery system

Sustained release of DNA from the surface of materials represents a promising approach to combine the gene therapy and implantable biomaterials. The nonviral chitosan-DNA complexes were incorporated into the multilayer via layer-by-layer deposition with hyaluronic acid (HA). The UV–vis spectroscopy and atomic force microscopy (AFM) results showed the successful construction of the nonviral complex contained multilayers. The complexes were releasable in physiological condition and a sustained release manner was gained when the multilayer was crosslinked. The cell viability test and the gene transfection assay showed that the natural polyelectrolyte-based nonviral complex incorporated multilayer not only had good cytocompatibility, but also possessed the in vitro gene transfection ability. This kind of surface-mediated nonviral complex incorporated multilayer may have great potential in the localized and controlled delivery of DNA in biomedical implants and tissue engineering application.     

Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model

In this paper, we have investigated sustained release biodegradable nanospheres for the delivery of plasmid DNA. The nanospheres were formulated using a proprietary co-polymer emulsion technique to encapsulate plasmid DNA. Gene transfection with nanospheres containing reporter genes (human placental alkaline phosphatase (AP) or Luciferase) was demonstrated in tissue culture (293T and COS-7 cells), and also in vivo in a nonunion femoral fracture (osteotomy) rat model. The bone gap was filled with nanospheres and gene expression in the implantation site was measured five weeks after the initial surgery. The nanospheres had a mean diameter of 230 nm, with a DNA loading of 0.7%w/w. These nanospheres demonstrated sustained release of the encapsulated DNA under in vitro physiologic conditions with an 82% cumulative DNA release over 17 days. The transfection efficiency of the nanospheres in tissue culture was two to five orders of magnitude greater than the gene expression with the same amount of plasmid DNA in solution. In the rat studies, the mean AP activity in the tissue retrieved from the osteotomy site in the experimental group was 291.8±52.5 cpm Versus 54.1±26.5 cpm (mean±S.E.M., P=0.03) in the sham control group. In conclusion, plasmid DNA nanospheres could be used as an effective nonviral method of gene delivery. In the future, nanospheres containing therapeutic genes, such as those encoding parathyroid hormone peptide, 1–34 amino acids (PTH-34) or Bone Morphogenic Protein-4 (BMP-4), could be used for the healing of nonunion bone fracture sites.     

聚乙二醇嵌段树枝状聚赖氨酸共聚物的合成及其基因载体研究

采用液相多肽合成法制备得到窄分子量分布、结构可控的生物相容性聚乙二醇嵌段共聚树枝状聚赖氨酸阳离子功能大分子(PEG-b-Dendritic PLL). 运用¹H NMR核磁共振、凝胶电泳以及荧光淬灭滴定手段对所得阳离子两嵌段大分子的化学结构及其与质粒DNA (pDNA)结合作用与复合行为进行了研究. 结果表明聚乙二醇嵌段树枝状聚赖氨酸与pDNA分子可以在缓冲溶液中形成稳定的胶束, pDNA与阳离子树枝赖氨酸嵌段通过静电相互作用形成胶束核, 其水溶性聚乙二醇嵌段形成水溶性胶束壳, 提高了阳离子大分子/pDNA复合胶束的稳定性. 同时发现随着阳离子嵌段树枝状赖氨酸代数的增加, 阳离子两嵌段大分子与pDNA的结合作用增强, 有利于其作为基因转染生物功能载体的应用.